Brii Biosciences Confirms 2025 PFIC Status, Issues Tax Statement for U.S. Holders

An update from Brii Biosciences Limited ( (HK:2137) ) is now available.

Brii Biosciences Limited has notified its U.S. shareholders that it met the definition of a Passive Foreign Investment Company for the tax year ended December 31, 2025, and has issued a PFIC Annual Information Statement for that period. The company confirms that for 2025 it recorded zero ordinary earnings, zero net capital gains and made no cash or property distributions per share, while offering U.S. investors access to its books and the data needed to make an optional Qualified Electing Fund election and comply with Form 8621 reporting.

The announcement has practical implications only for U.S. holders of Brii shares, who may face specific U.S. tax reporting and income inclusion requirements if they elect QEF treatment, but it does not indicate any operational change, dividend action or immediate financial impact on the broader shareholder base. By voluntarily publishing detailed PFIC information and allowing inspection of its records, Brii positions itself as proactive on cross‑border tax compliance, potentially easing the administrative burden and uncertainty for U.S. investors in the stock.

The most recent analyst rating on (HK:2137) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Brii Biosciences Limited stock, see the HK:2137 Stock Forecast page.

More about Brii Biosciences Limited

Brii Biosciences Limited is a Cayman Islands–incorporated biopharmaceutical company listed in Hong Kong under stock code 2137.HK. The company focuses on developing and commercializing innovative therapies, with a shareholder base that includes U.S. investors subject to U.S. federal tax rules on foreign investments.

Its operations and capital structure make it potentially relevant under specialized U.S. tax regimes such as the Passive Foreign Investment Company rules, requiring specific disclosures for U.S. shareholders.

Average Trading Volume: 1,257,314

Technical Sentiment Signal: Sell

Current Market Cap: HK$1.1B

For a thorough assessment of 2137 stock, go to TipRanks’ Stock Analysis page.